Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joachim Spranger

Showing results (1-10 of 227) with videos related to

Pageof 23
Sort By:
MMW Fortschritte Der Medizin|September 3, 2009
[Depot insulin with tumor risk. Changing now or staying cool? (interview by Sarah Pampel)]Joachim Spranger
Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS|April 13, 2011
[Pathophysiology of impaired insulin sensitivity in the perioperative period]Anke Assmann, Joachim Spranger
Deutsche Medizinische Wochenschrift (1946)|June 1, 2021
[New Developments in Type 1 Diabetes]Linus Haberbosch, Joachim Spranger
Gastroenterology|July 5, 2011
GLP-1-based therapies: the dilemma of uncertaintyJoachim Spranger, Ursula Gundert-Remy, Thomas Stammschulte
Expert Review of Endocrinology & Metabolism|August 12, 2022
Thyroid hormones as a disease modifier and therapeutic target in nonalcoholic steatohepatitisEva K Wirth, Tobias Puengel, Joachim Spranger, et al.
Deutsches Arzteblatt International|July 11, 2014
Skepticism is unjustifiedHeinz-Harald Abholz, Günther Egidi, Ulrich Alfons Müller, et al.
Reviews in Endocrine & Metabolic Disorders|December 24, 2021
Computational approaches to predicting treatment response to obesity using neuroimagingLeonard Kozarzewski, Lukas Maurer, Anja Mähler, et al.
Journal of Clinical and Translational Hepatology|August 14, 2023
Liver Fat Scores for Noninvasive Diagnosis and Monitoring of Nonalcoholic Fatty Liver Disease in Epidemiological and Clinical StudiesMona Reinshagen, Stefan Kabisch, Andreas F H Pfeiffer, et al.
BMC Medicine|July 27, 2022
Weight loss-induced improvement of body weight and insulin sensitivity is not amplified by a subsequent 12-month weight maintenance intervention but is predicted by adaption of adipose atrial natriuretic peptide system: 48-month results of a randomized controlled trialLinna Li, Dominik Soll, Verena Leupelt, et al.
Nutrition & Metabolism|March 29, 2022
Long-term impact of the metabolic status on weight loss-induced health benefitsDominik Soll, Julia Gawron, Laura Pletsch-Borba, et al.
Pageof 23

Showing results (1-10 of 227) with videos related to

Sort By:
Pageof 23
MMW Fortschritte Der Medizin|September 3, 2009
[Depot insulin with tumor risk. Changing now or staying cool? (interview by Sarah Pampel)]Joachim Spranger
Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS|April 13, 2011
[Pathophysiology of impaired insulin sensitivity in the perioperative period]Anke Assmann, Joachim Spranger
Deutsche Medizinische Wochenschrift (1946)|June 1, 2021
[New Developments in Type 1 Diabetes]Linus Haberbosch, Joachim Spranger
Gastroenterology|July 5, 2011
GLP-1-based therapies: the dilemma of uncertaintyJoachim Spranger, Ursula Gundert-Remy, Thomas Stammschulte
Expert Review of Endocrinology & Metabolism|August 12, 2022
Thyroid hormones as a disease modifier and therapeutic target in nonalcoholic steatohepatitisEva K Wirth, Tobias Puengel, Joachim Spranger, et al.
Deutsches Arzteblatt International|July 11, 2014
Skepticism is unjustifiedHeinz-Harald Abholz, Günther Egidi, Ulrich Alfons Müller, et al.
Reviews in Endocrine & Metabolic Disorders|December 24, 2021
Computational approaches to predicting treatment response to obesity using neuroimagingLeonard Kozarzewski, Lukas Maurer, Anja Mähler, et al.
Journal of Clinical and Translational Hepatology|August 14, 2023
Liver Fat Scores for Noninvasive Diagnosis and Monitoring of Nonalcoholic Fatty Liver Disease in Epidemiological and Clinical StudiesMona Reinshagen, Stefan Kabisch, Andreas F H Pfeiffer, et al.
BMC Medicine|July 27, 2022
Weight loss-induced improvement of body weight and insulin sensitivity is not amplified by a subsequent 12-month weight maintenance intervention but is predicted by adaption of adipose atrial natriuretic peptide system: 48-month results of a randomized controlled trialLinna Li, Dominik Soll, Verena Leupelt, et al.
Nutrition & Metabolism|March 29, 2022
Long-term impact of the metabolic status on weight loss-induced health benefitsDominik Soll, Julia Gawron, Laura Pletsch-Borba, et al.
Pageof 23